Literature DB >> 20680518

Treatment of acquired angioedema with icatibant: a case report.

Andrea Zanichelli, Matteo Badini, Ilaria Nataloni, Nicola Montano, Marco Cicardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20680518     DOI： 10.1007/s11739-010-0431-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management.

Authors:  Lorenza Chiara Zingale; Roberto Castelli; Andrea Zanichelli; Marco Cicardi
Journal:  Immunol Allergy Clin North Am       Date:  2006-11       Impact factor: 3.479

2.  Short-term prophylactic treatment of hereditary angioedema with icatibant.

Authors:  L Marqués; D Domingo; F J Maravall; J Clotet
Journal:  Allergy       Date:  2010-01       Impact factor: 13.146

Review 3.  Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.

Authors:  Marco Cicardi; Lorenza C Zingale; Emanuela Pappalardo; Anna Folcioni; Angelo Agostoni
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

4.  Autoimmune C1 inhibitor deficiency: report of eight patients.

Authors:  M Cicardi; G Bisiani; M Cugno; P Späth; A Agostoni
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

5.  Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.

Authors:  K Bork; G Witzke
Journal:  J Allergy Clin Immunol       Date:  1989-03       Impact factor: 10.793
  5 in total
  6 in total

1.  Treatment of ACEI-related angioedema with icatibant: a case series.

Authors:  Maria Bova; Mar Guilarte; Anna Sala-Cunill; Paolo Borrelli; Grazia Maria Luisa Rizzelli; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

2.  Icatibant and ACE inhibitor angioedema.

Authors:  Elizabeth Janet Illing; Sara Kelly; Jonathan Charles Hobson; Seema Charters
Journal:  BMJ Case Rep       Date:  2012-08-30

3.  Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.

Authors:  Albanne Branellec; Laurence Bouillet; Nicolas Javaud; Arsène Mekinian; Isabelle Boccon-Gibod; Claire Blanchard-Delaunay; Eric Oksenhendler; Yann Ollivier; Bertrand Dunogué; Stephanie Amarger; Denise Ponard; Christian Drouet; Luc Mouthon; Michel Thomas; Olivier Fain
Journal:  J Clin Immunol       Date:  2012-04-20       Impact factor: 8.317

4.  A consensus parameter for the evaluation and management of angioedema in the emergency department.

Authors:  Joseph J Moellman; Jonathan A Bernstein; Christopher Lindsell; Aleena Banerji; Paula J Busse; Carlos A Camargo; Sean P Collins; Timothy J Craig; William R Lumry; Richard Nowak; Jesse M Pines; Ali S Raja; Marc Riedl; Michael J Ward; Bruce L Zuraw; Deborah Diercks; Brian Hiestand; Ronna L Campbell; Sandra Schneider; Richard Sinert
Journal:  Acad Emerg Med       Date:  2014-04       Impact factor: 3.451

5.  In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.

Authors:  A L Manson; A Price; J Dempster; P Clinton-Tarestad; C Greening; R Enti; S Hill; S Grigoriadou; M S Buckland; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 6.  Angioedema: Classification, management and emerging therapies for the perioperative physician.

Authors:  Lopa Misra; Narjeet Khurmi; Terrence L Trentman
Journal:  Indian J Anaesth       Date:  2016-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.